Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ironwood Pharmaceuticals

0.7490
+0.02323.20%
Post-market: 0.75990.0109+1.46%18:56 EDT
Volume:1.55M
Turnover:1.16M
Market Cap:121.20M
PE:-3.70
High:0.7600
Open:0.7080
Low:0.6902
Close:0.7258
Loading ...

Ironwood Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Ironwood Pharma (IRWD) Has a New Rating from Craig-Hallum

TIPRANKS
·
27 Feb

Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates

Zacks
·
27 Feb

Ironwood: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Ironwood Pharmaceuticals 2025 Outlook: Expects Revenue Of $260M–$290M Vs. $287.583M Est., Sees Adjusted EBITDA Above $85M

Benzinga
·
27 Feb

Ironwood Pharmaceuticals Q4 2024 Adj EPS $0.02 Misses $0.08 Estimate, Sales $90.55M Miss $93.82M Estimate

Benzinga
·
27 Feb

BRIEF-Ironwood Pharmaceuticals Q4 Revenue USD 90.545 Million Vs. IBES Estimate USD 93.8 Million

Reuters
·
27 Feb

Ironwood Pharmaceuticals Inc - Outlook FY Total Revenue $260 - $290 Million

THOMSON REUTERS
·
27 Feb

Ironwood Pharmaceuticals Q4 Adjusted Ebitda USD 33.775 Million

THOMSON REUTERS
·
27 Feb

Ironwood Pharmaceuticals Q4 Basic EPS USD 0.02

THOMSON REUTERS
·
27 Feb

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Business Wire
·
27 Feb

Ironwood Pharmaceuticals Inc expected to post earnings of 8 cents a share - Earnings Preview

Reuters
·
25 Feb

Ironwood Pharma (IRWD) Receives a Buy from Craig-Hallum

TIPRANKS
·
24 Feb

Ironwood Pharmaceuticals Inc expected to post earnings of 8 cents a share - Earnings Preview

Reuters
·
21 Feb

Ironwood Pharmaceuticals Inc expected to post earnings of 8 cents a share - Earnings Preview

Reuters
·
18 Feb

Ironwood Pharmaceuticals Inc expected to post earnings of 8 cents a share - Earnings Preview

Reuters
·
14 Feb

Millrose Properties Set to Join S&P SmallCap 600

PR Newswire
·
06 Feb

S&P Dow Jones Indices: Millrose Properties to Replace Ironwood Pharmaceuticals in S&P Smallcap 600 Effective Prior to Market Open on Feb 10

THOMSON REUTERS
·
06 Feb

S&P Dow Jones Indices: Following the Spin-off, Lennar Will Remain in the S&P 500

THOMSON REUTERS
·
06 Feb

Sector Update: Health Care Stocks Gain Thursday

MT Newswires Live
·
31 Jan